Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C1orf167 antisense RNA 1 (C1orf167-AS1) is a long non-coding RNA gene located on chromosome 1 (locus: chr1:11777077-11779619, hg38)[1][6]. It is classified as an antisense RNA, meaning it is transcribed from the DNA strand opposite to the C1orf167 gene and may potentially regulate its expression or other nearby genes by mechanisms typical of natural antisense transcripts (NATs), such as modulating mRNA processing, translation, or chromatin state[2]. As of now, its biological function, disease relevance, and role as a drug target remain uncharacterized in the scientific literature and databases. There is no evidence it encodes a protein or has direct clinical or therapeutic applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C1orf167 antisense RNA 1 (C1orf167-AS1).